AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Reactive oxygen species gene signature predicts survival in sepsis

Detailed Technology Description

Title: Reactive oxygen species gene signature predicts survival in sepsis Invention: The technology is a 21-gene reactive oxygen species (ROS)-associated molecular signature that predicts survival in septic patients. Background: Sepsis syndrome’s mortality rate is 26% to 82% depending on whether septic shock occurs. Currently there are no reliable diagnostic biomarkers available to predict survival of patients with sepsis. Furthermore, researchers at the University of Arizona understand there is evidence indicating oxidative stress plays a role in the pathogenesis of sepsis. Applications: Diagnostic tool and/or service for patients with sepsis Advantages: Traditional biomarkers (C-reactive protein, interleukin-6, procalcitonin) are not reliable in predicting survivalROS-associated biomarkers were shown to predict the odds of patient's outcome Licensing Manager: Rakhi Gibbons rakhig@tla.arizona.edu(520) 626-6695

Country/Region

USA

For more information, please click Here